Around 4% of the global population suffers from a rare disease. Apart from the medical aspect, economic, organisational, and political approaches remain key aspects when it concerns the evolution of the world of rare diseases. We review here the principal specific national initiatives and organisations in Europe, North America and East Asia. Thereafter, we propose the outlines of a possible optimal approach, inspired by the successes of the individual national organisations. This work should be taken into account in the definition of large scale multi-national rare diseases programs, such as the European Joint Programme on Rare Diseases
Two years ago, at the ECRD in Krakow, we were celebrat-ing the recommendation of the Council of Mini...
Having codes for each and every rare disease (RD) would help European and national health authoritie...
An estimated 400 million individuals suffer from rare diseases globally. Tackling rare diseases has ...
Around 4% of the global population suffers from a rare disease. Apart from the medical aspect, econo...
Rare diseases imply clinical and economic burden as well as a significant challenge for health syste...
Rare diseases, also referred to as orphan diseases, are characterised by their low prevalence with m...
Rare diseases represent a major public health challenge due to their number, presently estimated to ...
Abstract Rare diseases collectively exert a global public health burden in the severity of their man...
ObjectiveRare diseases are often underdiagnosed, and their management is frequently complicated by a...
AbstractRare diseases are those with a particularly low prevalence; in Europe, diseases are consider...
As unanimously claimed within the rare disease community, cooperation between all stakeholders is a ...
The diagnosis and treatment of rare diseases have improved significantly in recent years. The length...
Rare diseases are those diseases that affect a small number of people when compared to the general p...
© 2020, Advanced Scientific Research. All rights reserved. Rare diseases are defined as diseases wit...
Abstract Background Calls have been made for governments to adopt a cohesive approach to rare diseas...
Two years ago, at the ECRD in Krakow, we were celebrat-ing the recommendation of the Council of Mini...
Having codes for each and every rare disease (RD) would help European and national health authoritie...
An estimated 400 million individuals suffer from rare diseases globally. Tackling rare diseases has ...
Around 4% of the global population suffers from a rare disease. Apart from the medical aspect, econo...
Rare diseases imply clinical and economic burden as well as a significant challenge for health syste...
Rare diseases, also referred to as orphan diseases, are characterised by their low prevalence with m...
Rare diseases represent a major public health challenge due to their number, presently estimated to ...
Abstract Rare diseases collectively exert a global public health burden in the severity of their man...
ObjectiveRare diseases are often underdiagnosed, and their management is frequently complicated by a...
AbstractRare diseases are those with a particularly low prevalence; in Europe, diseases are consider...
As unanimously claimed within the rare disease community, cooperation between all stakeholders is a ...
The diagnosis and treatment of rare diseases have improved significantly in recent years. The length...
Rare diseases are those diseases that affect a small number of people when compared to the general p...
© 2020, Advanced Scientific Research. All rights reserved. Rare diseases are defined as diseases wit...
Abstract Background Calls have been made for governments to adopt a cohesive approach to rare diseas...
Two years ago, at the ECRD in Krakow, we were celebrat-ing the recommendation of the Council of Mini...
Having codes for each and every rare disease (RD) would help European and national health authoritie...
An estimated 400 million individuals suffer from rare diseases globally. Tackling rare diseases has ...